Appeal announcement: Bortezomib monotherapy for relapsed multiple myeloma

The Institute has received four appeals against the Final Appraisal Determination and Guidance on this technology.

As set out in the Guidance for Appellants members of the public, including consultees and commentators for this appraisal, and the press, may request to attend the hearing. The number of observers admitted to the hearing will be limited to a number appropriate for the venue, and priority will be given to members of the public who are not employed by the appellants.

The hearing will be held at NICE, MidCity Place, 71 High Holborn, London, WC1V 6NA, on Thursday 08 February 2007 starting at 10.00am.

Members of the public will be able to register to attend the appeal hearing using this page from Thursday 21 December 2006. The Institute will not accept early requests to attend.

The names of the appellants will be published on this page on the day of the appeal.  The Institute will not comment on speculation as to the identity of appellants prior to publication of this information on the Institute’s website.

This page was last updated: 30 March 2010